Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Amgen
Pharma
Amgen to file 3rd-party review of Tavneos data for FDA hearing
A research firm is reviewing data on Amgen’s Tavneos as the company prepares for a hearing later this month which may determine the fate of the pill.
Kevin Dunleavy
Jun 12, 2026 11:12am
ADA: Amgen talks Repatha, GLP-1 hurdles as obesity plan advances
Jun 7, 2026 9:13pm
Tavneos patient starts resume in Japan amid safety scrutiny
May 21, 2026 11:38am
Amgen lures new CFO back from Galderma with hefty bonus
May 20, 2026 10:03am
Amgen adds $300M to US investment plan, targeting Puerto Rico
May 4, 2026 9:00am
Repatha helps Amgen overcome Prolia's LOE freefall in Q1
May 1, 2026 8:18am
